Transcatheter utilisation of lifetech multifunction™ occluder device for closure of perimembranous and muscular ventricular septal defects: first use in North America.
Sign Up to like & getrecommendations! Published in 2021 at "Cardiology in the young"
DOI: 10.1017/s1047951121001050
Abstract: Transcatheter closure of ventricular septal defects is considered first-line therapy when anatomically appropriate but is often challenged by proximity to the conduction system in perimembranous defects, or irregular defect shape, especially residual defects that may… read more here.
Keywords: ventricular septal; septal defects; first use; device ... See more keywords